Health In Tech Q1 Revenue Rises 9.4% to $8.8M, Guides $45M–$50M for 2026
Health In Tech's Q1 2026 revenue rose 9.4% to $8.8 million, but adjusted EBITDA swung to a $1.3 million loss and net loss reached $1.6 million, or $0.03 per share. It retains 2026 revenue guidance of $45m–$50m on $22.9m in contracted revenue and a 29.5% rise in distribution partners to 896.
1. Q1 2026 Financial Results
Health In Tech's revenue rose 9.4% to $8.8 million in Q1 2026, though adjusted EBITDA swung to a $1.3 million loss and net loss totaled $1.6 million, or $0.03 per diluted share.
2. Operational Metrics
Platform placed plan value reached $82.0 million and distribution partners grew 29.5% to 896, while cash and cash equivalents rose to $10.3 million and working capital increased to $15.0 million; contracted revenue for the remaining three quarters stands at $22.9 million.
3. 2026 Guidance and Outlook
The company reiterated 2026 revenue guidance of $45 million to $50 million, targeting 35%–50% year-over-year growth, underpinned by $22.9 million in contracted revenue and plans to expand its AI-enabled underwriting platform and distribution network.